Experiment: 8RVT

SOLID-STATE NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 13C-13C DARR	10 mg/L [U-100% 13C; U-100% 15N] Insulin chain A, 10 mg/mL [U-100% 13C; U-100% 15N] Insulin chain B	90% H2O/10% D2O	0.01 M	1.9	1 atm	298	Bruker AVANCE III 750
2	3D NCACX	10 mg/L [U-100% 13C; U-100% 15N] Insulin chain A, 10 mg/mL [U-100% 13C; U-100% 15N] Insulin chain B	90% H2O/10% D2O	0.01 M	1.9	1 atm	298	Bruker AVANCE III 750
3	3D NCOCX	10 mg/L [U-100% 13C; U-100% 15N] Insulin chain A, 10 mg/mL [U-100% 13C; U-100% 15N] Insulin chain B	90% H2O/10% D2O	0.01 M	1.9	1 atm	298	Bruker AVANCE III 750
4	3D CONCA	10 mg/L [U-100% 13C; U-100% 15N] Insulin chain A, 10 mg/mL [U-100% 13C; U-100% 15N] Insulin chain B	90% H2O/10% D2O	0.01 M	1.9	1 atm	298	Bruker AVANCE III 750
5	3D CANCO	10 mg/L [U-100% 13C; U-100% 15N] Insulin chain A, 10 mg/mL [U-100% 13C; U-100% 15N] Insulin chain B	90% H2O/10% D2O	0.01 M	1.9	1 atm	298	Bruker AVANCE III 750
6	2D 13C-13C PAR	10 mg/L [U-100% 13C; U-100% 15N] Insulin chain A, 10 mg/mL [U-100% 13C; U-100% 15N] Insulin chain B	90% H2O/10% D2O	0.01 M	1.9	1 atm	298	Bruker AVANCE III 750
7	2D 15N-15N PAR	10 mg/L [U-100% 13C; U-100% 15N] Insulin chain A, 10 mg/mL [U-100% 13C; U-100% 15N] Insulin chain B	90% H2O/10% D2O	0.01 M	1.9	1 atm	298	Bruker AVANCE III 750

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE III	750

NMR Refinement
Method	Details	Software
simulated annealing		ARIA

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	100
Conformers Submitted Total Number	10
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	chemical shift assignment	CcpNmr Analysis	2.4	CCPN
2	structure calculation	ARIA		Linge, O'Donoghue and Nilges
3	refinement	CNS		Brunger, Adams, Clore, Gros, Nilges and Read
4	peak picking	CcpNmr Analysis	2.4	CCPN

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.